ClinicalTrials.Veeva

Menu
S

Sneeze, Wheeze and Itch Associates | Normal, IL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

azelastine hydrochloride
fluticasone propionate
azelastineHcl
beclomethasone dipropionate
azelastine Hcl
BLU-5937
Omalizumab
QVAR
azelastine HCl
Asimadoline

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 18 total trials

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-1)

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).

Enrolling
Refractory Chronic Cough
Drug: BLU-5937
Drug: Placebo

Trial sponsors

Meda Pharmaceuticals logo
Teva Pharmaceuticals logo
Allergy Therapeutics logo
B
C
Novartis logo
T

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems